Background: A panel of academic psychiatrists and pharmacists, clinicians from the Texas
public mental health system, advocates, and consumers met in June 2006 in Dallas, Tex., to …

Background: The Texas Medication Algorithm Project (TMAP) has been a public-academic
collaboration in which guidelines for medication treatment of schizophrenia, bipolar …

The Texas Medication Algorithm Project is a program designed to improve the quality of care
of persons with serious mental disorders across sites in the Texas public mental health …

Background: In the Texas Medication Algo-rithm Project (TMAP), detailed guidelines for
medication management of schizophrenia and related disorders, bipolar disorders, and …

Background: The Texas Medication Algorithm Project (TMAP), a public-academic
collaborative effort, is a 3-phase project to develop, implement, and evaluate medication …

In light of the large number of studies published since the 2004 update of Schizophrenia
Patient Outcomes Research Team psychopharmacological treatment recommendations, we …

Originally published in February 2004. This guideline is more than 5 years old and has not
yet been updated to ensure that it reflects current knowledge and practice. In accordance …

Objective: To comprehensively review the 2 recent and large antipsychotic effectiveness
trials for treatment of schizophrenia: the United Kingdom's Cost Utility of the Latest …

Abstract The Schizophrenia Patient Outcomes Research Team (PORT) project has played a
significant role in the development and dissemination of evidence-based practices for …

OBJECTIVE: The Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study
examined the comparative effectiveness of antipsychotic treatments for individuals with …